Free Trial

Itron's (ITRI) "Equal Weight" Rating Reaffirmed at Stephens

Itron logo with Computer and Technology background

Key Points

  • Itron's stock has been reaffirmed with an "equal weight" rating by Stephens, setting a price objective of $130.00, suggesting a potential upside of 3.22% from its last closing.
  • The company reported earnings of $1.62 EPS for the last quarter, exceeding estimates by $0.29, although revenue was slightly down 0.4% year-over-year at $606.76 million.
  • Ten analysts currently hold a "Buy" rating on Itron, while the consensus target price stands at $137.10, indicating positive market sentiment towards the company's stock.
  • MarketBeat previews top five stocks to own in November.

Itron (NASDAQ:ITRI - Get Free Report)'s stock had its "equal weight" rating reissued by equities researchers at Stephens in a research report issued on Tuesday,Benzinga reports. They currently have a $130.00 price objective on the scientific and technical instruments company's stock. Stephens' price objective would indicate a potential upside of 3.22% from the stock's previous close.

A number of other research firms have also weighed in on ITRI. Weiss Ratings restated a "buy (b)" rating on shares of Itron in a report on Saturday, September 27th. Johnson Rice downgraded shares of Itron from a "buy" rating to an "accumulate" rating in a research report on Friday, August 1st. Guggenheim restated a "buy" rating and issued a $155.00 target price (up previously from $133.00) on shares of Itron in a research note on Monday, July 14th. Roth Capital increased their price target on Itron from $130.00 to $150.00 and gave the company a "buy" rating in a research report on Tuesday, July 22nd. Finally, TD Cowen raised their target price on Itron from $139.00 to $145.00 and gave the company a "buy" rating in a research report on Friday, June 20th. Ten analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $137.10.

View Our Latest Research Report on Itron

Itron Trading Up 0.4%

NASDAQ ITRI opened at $125.94 on Tuesday. Itron has a 52 week low of $90.11 and a 52 week high of $140.04. The business has a 50 day moving average price of $123.82 and a 200-day moving average price of $119.44. The company has a quick ratio of 1.75, a current ratio of 2.04 and a debt-to-equity ratio of 0.48. The company has a market cap of $5.76 billion, a price-to-earnings ratio of 21.53, a P/E/G ratio of 0.69 and a beta of 1.48.

Itron (NASDAQ:ITRI - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 EPS for the quarter, beating analysts' consensus estimates of $1.33 by $0.29. Itron had a net margin of 11.05% and a return on equity of 19.69%. The business had revenue of $606.76 million during the quarter, compared to analyst estimates of $610.36 million. During the same quarter in the previous year, the business posted $1.21 EPS. Itron's quarterly revenue was down .4% on a year-over-year basis. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. As a group, equities analysts expect that Itron will post 5.33 earnings per share for the current fiscal year.

Insider Activity

In related news, CFO Joan S. Hooper sold 970 shares of Itron stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $121,550.70. Following the completion of the transaction, the chief financial officer directly owned 88,394 shares in the company, valued at approximately $11,076,652.14. The trade was a 1.09% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP John F. Marcolini sold 565 shares of the business's stock in a transaction on Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $70,800.15. Following the sale, the senior vice president directly owned 14,396 shares in the company, valued at $1,803,962.76. The trade was a 3.78% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 3,037 shares of company stock valued at $380,566. 1.45% of the stock is currently owned by corporate insiders.

Institutional Trading of Itron

A number of institutional investors have recently added to or reduced their stakes in the stock. Impax Asset Management Group plc bought a new position in shares of Itron in the second quarter valued at approximately $91,998,000. Norges Bank bought a new position in Itron in the 2nd quarter valued at $71,727,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Itron by 129.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 732,274 shares of the scientific and technical instruments company's stock valued at $76,713,000 after purchasing an additional 413,487 shares in the last quarter. Merewether Investment Management LP increased its holdings in shares of Itron by 1,552.7% in the second quarter. Merewether Investment Management LP now owns 300,787 shares of the scientific and technical instruments company's stock worth $39,593,000 after purchasing an additional 282,587 shares during the period. Finally, Handelsbanken Fonder AB increased its holdings in shares of Itron by 21.2% in the second quarter. Handelsbanken Fonder AB now owns 943,564 shares of the scientific and technical instruments company's stock worth $124,201,000 after purchasing an additional 165,300 shares during the period. Hedge funds and other institutional investors own 96.19% of the company's stock.

Itron Company Profile

(Get Free Report)

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

Read More

Analyst Recommendations for Itron (NASDAQ:ITRI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Itron Right Now?

Before you consider Itron, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.

While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.